Last week I had a startup entrepreneur come to me with an idea about how to "pivot" his company strategy. The company, which had begun as a medical device company but couldn't quite find it's market, was considering re-emerging as a consumer-focused digital medical device company in an adjacent market.
The pharmaceutical company Mylan has developed a reputation for fighting tooth-and-nail to promote its flagship product, the EpiPen.
Bristol-Myers shuffles management and its chief strategy officer is leaving | STAT
Following setbacks with an important cancer drug, Bristol-Myers Squibb reorganized some key managerial slots last week and, as part of the shuffling, chief strategy officer Emmanuel Blin will leave in June, according to a memo written by chief executive officer Giovanni Caforio.
The country has grown increasingly dependent on the health sector to power the economy, and it will be a tough habit to break. Thirty-five percent of the nation's job growth has come from health care since the recession hit in late 2007, the single biggest sector for job creation.